# FDA 483_RESPONSE - Eli Lilly & Company - March 16, 2021

Source: https://www.globalkeysolutions.net/records/483_response/eli-lilly-company/48bca0f9-fb52-4f51-9e65-4d0fd6283a21

> FDA 483_RESPONSE for Eli Lilly & Company on March 16, 2021. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483_RESPONSE
- Company Name: Eli Lilly & Company
- Inspection Date: 2021-03-16
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations I

## Related Documents

- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/eli-lilly-company/15ef318d-09d2-403d-a119-ae8f9a4a6fc9)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/eli-lilly-company/fb465d0f-eee0-4efe-b1ef-fd636964c59d)
- [EIR - 2020-01-17](https://www.globalkeysolutions.net/records/eir/eli-lilly-company/00535940-b628-4bcd-aa01-17eb95be770e)
- [EIR - 2023-05-18](https://www.globalkeysolutions.net/records/eir/eli-lilly-company/15f9ed35-a475-4557-b1f2-753ea60f17a2)
- [483 - 2022-10-21](https://www.globalkeysolutions.net/records/483/eli-lilly-company/18ee6771-3641-4129-8c43-efe275d11ed4)

## Related Officers

- [Program Division Director](https://www.globalkeysolutions.net/people/art-o-czabaniuk/37f1e249-9ee6-4275-9c28-391d93659b85)
- [Ms.](https://www.globalkeysolutions.net/people/ann-connery/49b086d7-8b1c-4399-9666-b7d96b340e71)
- [Ainhoa Nieto](https://www.globalkeysolutions.net/people/ainhoa-nieto/89b22b5d-c0a2-4f0f-9c2c-8244b5cbb793)
- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/kenneth-o-gee/d61312c0-1422-4487-a5d6-ec6e76d242ee)
- [Director of Compliance](https://www.globalkeysolutions.net/people/nicholas-f-lyons/e52983af-3992-493c-addd-ff1dfa59eefb)

Company: https://www.globalkeysolutions.net/companies/eli-lilly-company/fc56eed7-d261-4de3-865e-c2aa54162adf

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-i/6ded4818-ee3a-46a1-84c1-36de58502b02